The budget has also focused on the start-up ecosystem and provided a fillip through the abolition of the ‘angel tax’ which is aimed at spurring investments in start-ups, and the emphasis on ‘ease of doing business’ will benefit Medium Small Micro Enterprises, she noted.
The government’s focus on research and innovation, especially agritech and industrial research, is a welcome move, the Biocon chief said.
The allocation of Rs 1 lakh crore financial pool will spur private sector-driven research and innovation at commercial scale, she opined. “We will need to read the details to see how this will be allocated to each sector. The removal of Customs duty on three cancer drugs will provide relief to cancer patients,” Shaw said. She, however, pointed out that the government should consider GST exemption for all cancer drugs to make cancer care more affordable for patients.